News

The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

EU 2026 Pharma Package Finalized: New Regulatory Framework Reshapes Exclusivity and Innovation Incentives

Friday, April 10, 2026

The EU Council has released the final texts of the Pharma Package introducing a flexible exclusivity model and new vouchers for antimicrobials amid ongoing legislative steps

Nxera Pharma Reaches Second Development Milestone in Eli Lilly Collaboration for Metabolic Diseases

Thursday, April 09, 2026

Nxera Pharma Co Ltd has reached a second development milestone under its multitarget collaboration and licence agreement with Eli Lilly and Company focused on diabetes and metabolic diseases

Axplora Invests €30 Million to Boost Lyophilization Capacity at Le Mans Facility

Thursday, April 09, 2026

Axplora announces a million investment to enhance lyophilization capabilities at its Le Mans manufacturing facility strengthening European pharma production capacity

EU Council Publishes Final 2026 Pharma Package: New Regulatory Framework for Medicinal Products

Wednesday, April 08, 2026

The EU Council has released the final texts of the comprehensive Pharma Package introducing flexible data protection periods orphan drug incentives and antimicrobial vouchers to boost innovation and access

Alloy Therapeutics Partners with Biogen on Multi-Target ASO Platform Collaboration

Wednesday, April 08, 2026

Alloy Therapeutics Inc has entered into a collaboration and licence agreement with Biogen Inc to support the development of antisense therapeutics using its proprietary AntiClastic ASO platform

Novo Foundation Pumps $850M into Denmark and Europe to Bolster Life Sciences Innovation

Tuesday, April 07, 2026

The Novo Foundation has announced an million investment to support biotech and pharma innovation across Denmark and Europe

EU Pharma Package Agreement Reached: Modernising Regulations for Medicinal Products and Enhancing Supply Security

Friday, April 03, 2026

The European Parliament and Council have agreed on the Pharma Package to modernise EU medicinal product regulations boost supply security and improve competitiveness

FORE Biotherapeutics Secures Breakthrough Therapy Status for Plixorafenib

Thursday, April 02, 2026

FORE Biotherapeutics has received Breakthrough Therapy Designation from the US Food and Drug Administration for plixorafenib a targeted therapy for adult patients with BRAF VEmutated highgrade glioma

EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026

Thursday, April 02, 2026

The European Union has introduced a comprehensive health package that enhances biopharma competitiveness through biotech act reforms and streamlined clinical trial processes ahead of

Axplora Invests €30 Million to Boost Lyophilization Capacity at Le Mans Facility

Wednesday, April 01, 2026

Axplora is investing million to enhance its lyophilization capabilities at its Le Mans manufacturing facility in France strengthening European pharma production capacity